These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35655404)

  • 1. Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings.
    Sukhanova M; Obeidin F; Streich L; Alexiev BA
    Genes Chromosomes Cancer; 2022 Nov; 61(11):653-661. PubMed ID: 35655404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor".
    Cloutier JM; Charville GW; Mertens F; Sukov W; Fritchie K; Perry KD; Edgar M; Rowsey RA; Folpe AL
    Mod Pathol; 2021 Apr; 34(4):758-769. PubMed ID: 33318583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
    Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
    Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma.
    Nord KH; Paulsson K; Veerla S; Wejde J; Brosjö O; Mandahl N; Mertens F
    Neoplasia; 2012 Sep; 14(9):807-12. PubMed ID: 23019412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
    Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
    Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
    Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
    Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Rhabdomyoblastic Tumor: From a Nebulous Smooth Muscle Neoplasm to a Novel Skeletal Muscle Tumor Subtype.
    Michal M
    Surg Pathol Clin; 2024 Mar; 17(1):65-76. PubMed ID: 38278608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
    Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
    Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration biopsy diagnosis of histiocyte-rich rhabdomyoblastic tumor (inflammatory leiomyosarcoma): A case report.
    McHugh KE; Kilpatrick SE
    Diagn Cytopathol; 2023 Apr; 51(4):E109-E112. PubMed ID: 36519516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnoses.
    Bourgeau M; Martinez AP
    Virchows Arch; 2021 Feb; 478(2):367-373. PubMed ID: 32514584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
    Middeldorp A; van Eijk R; Oosting J; Forte GI; van Puijenbroek M; van Nieuwenhuizen M; Corver WE; Ruano D; Caldes T; Wijnen J; Morreau H; van Wezel T
    Int J Cancer; 2012 Feb; 130(4):837-46. PubMed ID: 21445971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature.
    Arbajian E; Köster J; Vult von Steyern F; Mertens F
    Mod Pathol; 2018 Jan; 31(1):93-100. PubMed ID: 28884746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic aberrations and heterogeneity of mutations in repeat-containing genes in a colon carcinoma from a patient with hereditary nonpolyposis colorectal cancer.
    Planck M; Halvarsson B; Pålsson E; Hallén M; Ekelund M; Pålsson B; Baldetorp B; Nilbert M
    Cancer Genet Cytogenet; 2002 Apr; 134(1):46-54. PubMed ID: 11996796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.
    Christacos NC; Quade BJ; Dal Cin P; Morton CC
    Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A; Thiel F; Hartmann A; Fukunaga M
    Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
    Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing.
    Lee PJ; Yoo NS; Hagemann IS; Pfeifer JD; Cottrell CE; Abel HJ; Duncavage EJ
    Exp Mol Pathol; 2017 Feb; 102(1):156-161. PubMed ID: 28093192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
    Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
    Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type.
    David MP; Venkatramani R; Lopez-Terrada DH; Roy A; Patil N; Fisher KE
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.
    Nambirajan A; Jain D
    Semin Diagn Pathol; 2021 Sep; 38(5):83-89. PubMed ID: 34147303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.